期刊名称：BIOLOGICAL & PHARMACEUTICAL BULLETIN
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
We cordially invite you to subscribe to the Chemical & Pharmaceutical Bulletin (CPB) and the Biological & Pharmaceutical Bulletin (BPB), which are the main journals published in English by the Pharmaceutical Society of Japan. Originally, CPB covered all aspects of the pharmaceutical sciences, however, since the topics covered by the journal became increasingly diverse, a new sister journal, BPB was created in 1993. Thus, CPB covers physical and inorganic chemistry, organic chemistry including natural products chemistry, medicinal chemistry, analytical chemistry, pharmacognosy, and physical pharmacy, while BPB covers analytical biochemistry, biochemistry/molecular biology, pharmacology, toxicology, medicinal chemistry, pharmacognosy, and biopharmacy.
Instructions to Authors
The Journal will accept original and innovative submissions in English from both members, and non-members of the Pharmaceutical Society of Japan, on the understanding that the work is unpublished and is not being considered for publication elsewhere. TYPES OF MANUSCRIPT
The Journal publishes Regular Articles, Notes, Communications, and Reviews. With the exception of Invited Reviews, manuscripts will be reviewed by two or more members of the editorial board, whose opinions will form the basis of the final decision by the editor.
It is recommended that an English check of the manuscript by a native speaker has been completed before submission. If English checkers are not available, English check at the Pharmaceutical Society of Japan will be performed.
- Regular Articles: New, significant, innovative, and original findings are suitable as Regular Articles.
- Notes: Papers containing new facts and important data derived from incomplete or partial studies may be suitable as a Note. In general, the papers should not exceed 4 printed pages.
- Communications: Communications should contain new and important information that interests readers of theJOURNAL and urgent publication is desirable. An explanatory statement is required for urgent publication. In general,the papers should not exceed 2 printed pages. Indicate "Communication" in red on the envelope.
- Reviews:
i) Regular Reviews: Describing the research results of the author.
ii) Invited Reviews: Reviews are submitted by invitation from the editorial board, and encompass recent important scientific discoveries.
- SUBMISSION OF MANUSCRIPTS
- All manuscripts (in duplicate) should be submitted to:
- Biological & Pharmaceutical Bulletin Editorial Office
- The Pharmaceutical Society of Japan
- 2¨C12¨C15, Shibuya, Shibuya-ku, Tokyo 150¨C0002, Japan
- MANUSCRIPT PREPARATION
- 1. Manuscript Form. All manuscripts should be typewritten in English on A4-size white paper, double spaced. All subsequent pages should be numbered consecutively.
- i) Title Page. The title page (page 1) should start with the type of manuscript (Regular Article, Notes etc.). This should be followed by the appropriate section for the manuscript (i.e. one of the follows: Analytical Biochemistry, Biochemistry/Molecular Biology, Pharmacology, Toxicology, Medicinal Chemistry, Pharmacognosy, Biopharmacy, Miscellaneous.), the title, name(s) of the author(s) and affiliation, mailing address, and E-mail address. An asterisk (*) should be added to the right of the corresponding author's name. For contribution from Japan, the corresponding author's name and address in Japanese, telephone number, fax number, and E-mail address should be given at the bottom right.
- Examples of affiliation and mailing address are as follows:
- a Graduate Institute of Medical Sciences, Taipei Medical University; b Department of Pharmacology, Taipei Medical University; c Department of Pathology, Taipei Medical University; and d Graduate Institute of Biomedical Technology, Taipei Medical University; No. 250, Wu-Shing St., Taipei 110, Taipei, Taiwan.
- ii) Summary and Keywords. Page 2 should contain a summary of less than 250 words and 3 to 6 descriptive keywords, listed in order of importance. The first 3 keywords must be independent, as they will be used in a keyword combination in the index (less than 80 characters).
- iii) Main Text. The text, acknowledgments, and references should be presented in this order. Figures, tables, and charts showing chemical structures should be collected at the end, each on a separate sheet. All pages should be numbered consecutively.
- 2. Figures, Tables and Charts Showing Chemical Structure. In principle, figures, tables, and charts showing chemical structures prepared by the author(s) will be used in the printed version of the journal. All chemical structures, figures, and tables should be numbered consecutively with Arabic numbers, and figure titles and legends are to be typed consecutively on a separate sheet. All figures, tables and charts should be prepared on A4-size white paper.
- 3. Abbreviations. Abbreviation must be spelled out in full at their initial appearance, followed by the abbreviation in parentheses. Thereafter, the abbreviation may be employed.
However, the following need not be defined: AIDS (acquired immunodeficiency syndrome), ATP (adenosine 5'-triphosphate), cAMP(adenosine 3',5'-cyclic monophosphate), cDNA (complementary DNA), CoA (coenzyme A), DNA (deoxyribonucleic acid), ED50 (50% effective dose), ESCA (electron spectroscopy for chemical analysis), ESR (electron spin resonance), FAB-MS (fast atom bombardment mass spectrometry), FAD (flavin adenine dinucleotide), GC-MS (gas chromatography-mass spectrometry), HOMO (highest occupied molecular orbital), HPLC (high-pressure liquid chromatography, high-performance liquid chromatography), IC50 (inhibitory concentration, 50%), IR (infrared), LD50 (50% lethal dose), LUMO (lowest unoccupied molecular orbital), MO (molecular orbital), mRNA (messenger RNA), MS (mass spectrum), NMR (nuclear magnetic resonance, as 13C-NMR, 1H-NMR), P450 (as in cytochrome P450), RNA (ribonucleic acid), rRNA (ribosomal RNA), STO (Slater-type orbital, as STO 3G), TLC (thinlayer chromatography), tRNA (transfer RNA), UV (ultraviolet)
- 4. Units. The following units should be used: length (m, cm, mm, ¦Ìm, nm, Å), mass (kg, g, mg, ¦Ìg, ng, pg, mol, mmol), volume (l, ml, ¦Ìl), time (s, min, h, d), temperature (¡ãC, K), radiation (Bq, Ci, dpm, Gy, rad), concentration (M, mM, mol/l, mmol/l, mg/ml, ¦Ìg/ml, %, % (v/v), % (w/v), ppm, ppb)
- 5. Spectral and Elemental Analysis Data. Please report spectral and elemental analysis data in the following format. 1H-NMR (CDCl3) ¦Ä: 1.25 (3H, d, J=7.0 Hz), 3.55 (1H, q, J=7.0 Hz), 6.70 (1H, m). 13C-NMR (CDCl3) ¦Ä: 20.9 (q), 71.5 (d), 169.9 (s). IR (KBr) cm-1: 1720, 1050, 910. UV ¦Ëmax (EtOH) nm (¦Å): 241 (10860), 288 (9380). UV ¦Ëmax (H2O) nm (log ¦Å): 280 (3.25). FAB-MS m/z: 332.1258 (Calcd for C18H20O6: 332.1259). MS m/z: 332 (M+), 180, 168. [¦Á]D23 -74.5 (c=1.0, MeOH). Anal. Calcd for C19H21NO3: C, 73.29; H, 6.80; N,4.50. Found: C, 73.30; H, 6.88; N, 4.65.
- 6. Nomenclature. The nomenclature of chemical compounds shall be in accordance with the nomenclature rules formulated by IUPAC. Alternatively, naming may conform to the nomenclature in the index of Chemical Abstracts or the Ring Index.
- 7. References. References should be placed and numbered in the order of appearance in the text. Each number is to be positioned after the last relevant word with a right-half parenthesis mark, and all references should be collected together at the end of the text as References and Notes. Abbreviations for Journals should confirm to Chemical Abstracts.
- Examples of references are as follows:
- 1) Roques B. P., Florentin D., Callanquin M., J. Heterocycl. Chem., 12, 195-196 (1975).
- 2) Cruickshank R., Duguid I. P., Marmion B. P., Swain R. H. A., "Medical Microbiology," 12nd ed., Vol. III, Churchill Livingstone, New York, 1975.
- 3) Szejtli J., "Cyclodextrin Technology," ed. by Davis J. E. D., Kluwer Academic, Dordrecht, 1988.
- 4) Tokuda H., Ichiishi E., Onozuka M., Yamaguchi S., "Biology of Nitric Oxide, Part 6," Vol. I Chap. 2, eds. by Moncada S., Tada N., Maeda H., Portland Press, London, 1998, pp. 185¡ª186.
- 5) Frömming K.-H., Szejtli J.: <http://www.bpb.com/>, PSJ Web, 25 November 1999.
- 6) Based on a lecture presented at the 30th Symposium on Heterocyclic Chemistry, Tokyo University of Pharmacy & Life Science, Hachioji, on 25 November 1999.
X-RAY CRYSTAL STRUCTURE ANALYSES
When structure determination by X-ray crystallographic analysis is a central theme of the paper, the data required for registration with the Cambridge Crystallographic Data Centre (CCDC) should be attached as supplementary material. Although this does not apply in cases where crystallographic analysis plays only a supplementary role, crystal data (unit cell parameters, space group, Z density) and R-factor should still be noted. Atomic coordinates will be printed when the structure is important. Bond lengths and angles, thermal parameters, and torsion angles will be printed when they are important for the issues addressed in the paper. When papers have been accepted, the authors are advised to register the data with CCDC.
ETHICS
In scientific investigations involving human subjects, experiments should be performed in accordance with the ethical standards formulated in the Helsinki Declaration of 1964 (revised in 2000,cf. http://ohsr.od.nih.gov/).Similarly, animal experiments should follow the ethical standards formulated in the guidelines issued by the Science and International Affairs Bureau of the Japanese Ministry of Education, Science, Sports and Culture, No. 141, 1987: "Animal Experiments in Universities etc."
PAGE CHARGES
Requested to pay for publication. Charge may be modified without preliminary announcement
- Page Charge: 4,000 Japanese yen per printed page (not including tax).
- Reprint Charges (Japanese yen)
- Number of Pages
|
| Number of Reprints | |
1-2 |
3-4 |
5-6 |
7-8 |
9-10 |
Greater than 11 |
| 50 |
8000 |
9000 |
10000 |
11000 |
12000 |
13000 |
| 100 |
14400 |
16200 |
18000 |
19800 |
21600 |
23400 |
| 150 |
19200 |
21600 |
24000 |
26400 |
28800 |
31200 |
| 200 |
22400 |
25200 |
28000 |
30800 |
33600 |
36400 |
| More than 250 |
110 each |
120 each |
130 each |
150 each |
160 each |
180 each |
| Postage included; Tax extra. |
¡¤ Color printing carries on extra surcharge of 80(Japanese yen) per page. |
| ¡¤ Reprints only available in multiples of 50. |
¡¤ Cover charge: 30(Japanese yen) each. |
Actual cost for color figures.
Actual cost for an English check.
The payment of page charge is required, but is not a condition for publication, since the decision for publication is made on the basis of scientific significance only. The publication charge may be waived upon request from authors who do not have funds. No free reprints of the article are provided.
MISCELLANEOUS
- Revised manuscripts must be returned with in 2 months, otherwise they will be treated as new submissions.
- A floppy disk containing text and figure files must be sent with the revised manuscript.
- The author is given an opportunity to proof the galley of an accepted manuscript. Major changes at this time are not permitted.
- The copyrights of all manuscripts published in the Biological & Pharmaceutical Bulletin belong to the Pharmaceutical Society of Japan. The author must submit a Copyright Transfer form to the Pharmaceutical Society of Japan.
Editorial Board
Editor-in-chief
Prof. Yasuyuki Nomura [Graduate School of Pharmaceutical Sciences, Hokkaido University]
Editors
Takemi Enomoto [Graduate School of Pharmaceutical Sciences, Tohoku University]
Hideyoshi Harashima [Graduate School of Pharmaceutical Sciences, Hokkaido University]
Osamu Hazeki [Graduate School of Biomedical Sciences, Hiroshima University]
Hiroshi Homma [School of Pharmaceutical Sciences, Kitasato University]
Tsuneo Imanaka [Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University]
Ken-ichi Inui [Department of Pharmacy, Kyoto University Hospital]
Nobuyuki Itoh [Graduate School of Pharmaceutical Sciences, Kyoto University]
Ichiro Kudo [School of Pharmaceutical Sciences, Showa University]
Yoshinori Moriyama [Faculty of Pharmaceutical Sciences, Okayama University]
Toshihiko Murayama [Graduate School of Pharmaceutical Sciences, Chiba University]
Ikuo Saiki [Institute of Natural Medicine, Toyama Medical and Pharmaceutical University]
Tsutomu Suzuki [School of Pharmacy and Pharmaceutical Sciences, Hoshi University]
Tetsuya Terasaki [Graduate School of Pharmaceutical Sciences, Tohoku University]
Masaaki Tsuda [Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University]
Masafumi Tsujimoto [Laboratory of Cellular Biochemistry, RIKEN]
Hiroshi Ueda [Graduate School of Biomedical Sciences, Nagasaki University]
Hideo Utsumi [Graduate School of Pharmaceutical Sciences, Kyushu University]
Masatoshi Yamazaki [Faculty of Pharmaceutical Sciences, Teikyo University]
Yukio Yoneda [Graduate School of Natural Science and Technology, Kanazawa University]
Kenneth L. Audus [University of Kansas]
William E. M. Lands [National Inst. on Alcohol Abuse & Alcoholism]
Takami Oka [LMCB/NIDDK, NIH]
Editorial Section
Hitoshi Aoyagi
Junko Atsumi
Editorial Office The Pharmaceutical Society of Japan
2¨C12¨C15, Shibuya, Shibuya-ku, Tokyo 150¨C0002, Japan
Telephone: +81¨C3¨C3406¨C3325 Fax: +81¨C3¨C3498¨C1835 E-mail: ronb@pharm.or.jp
Notice about photocopying
In order to photocopy any work from this publication, you or your organization must obtain permission from the following organization which has been delegated for copyright for clearance by the copyright owner of this publication.
Japan Academic Association for Copyright Clearance (JAACC)
9¨C6¨C41, Akasaka, Minato-ku, Tokyo 107¨C0052, Japan
TEL: +81¨C3¨C3475¨C5618 FAX: +81¨C3¨C3475¨C5619 E-mail: naka-atsu@muj.biglobe.ne.jp
|
